Epstein-Barr virus induced acute hepatitis with hyperferritinemia: A rare presentation

Odumade, 2011, Progress and problems in understanding and managing primary Epstein-Barr virus infections, Clin Microbiol Rev, 24, 193, 10.1128/CMR.00044-10 Shapiro, 1988, Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation, Blood, 71, 1234, 10.1182/blood.V71.5.1234.1234 Thoufeeq, 2007, A case of acute infectious mononucleosis presenting with very high ferritin, World J Gastroenterol, 13, 637, 10.3748/wjg.v13.i4.637 Dematapitiya, 2019, Cold type autoimmune hemolytic anemia- a rare manifestation of infectious mononucleosis; serum ferritin as an important biomarker, BMC Infect Dis, 19, 68, 10.1186/s12879-019-3722-z Goudarzipour, 2013, Epstein-barr virus-induced hemophagocytic lymphohistiocytosis, Int J Hematol Oncol Stem Cell Res, 7, 42 Kushner, 1982, The phenomenon of the acute phase response, Ann N Y Acad Sci, 389, 39, 10.1111/j.1749-6632.1982.tb22124.x Horvat, 2019, C-Reactive protein and ferritin are associated with organ dysfunction and mortality in hospitalized children, Clin Pedia (Philos), 58, 752, 10.1177/0009922819837352 Vine, 2012, Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis, Aliment Pharm Ther, 36, 16, 10.1111/j.1365-2036.2012.05122.x Moniri, 2017, Acute Epstein-Barr virus hepatitis without mononucleosis syndrome: a case report, Gastroenterol Hepatol Bed Bench, 10, 147 Salva, 2013, Epstein-Barr virus-associated cholestatic hepatitis, BMJ Case Rep, 10.1136/bcr-2013-202213 Shah, 2020, Acute liver injury due to severe Epstein-Barr virus infection, ACG Case Rep J, 7, 10.14309/crj.0000000000000325 Van de Veerdonk, 2012, IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity, J Infect Dis, 206, 197, 10.1093/infdis/jis335 Petrova, 2010, Epstein-Barr virus: silent companion or causative agent of chronic liver disease, World J Gastroenterol, 16, 4130, 10.3748/wjg.v16.i33.4130 Rigopoulou, 2012, Epstein-Barr virus as a trigger of autoimmune liver diseases, Adv Virol, 10.1155/2012/987471 Xu, 2012, An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein–Barr virus activation, J Natl Cancer Inst, 104, 1396, 10.1093/jnci/djs320 Gershburg, 2005, Epstein–Barr virus infections: prospects for treatment, J Antimicrob Chemother, 56, 277, 10.1093/jac/dki240